rs28940576
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_198586.3(NHLRC1):βc.205C>Gβ(p.Pro69Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000123 in 1,584,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (β β ).
Frequency
Genomes: π 0.000079 ( 0 hom., cov: 33)
Exomes π: 0.00013 ( 0 hom. )
Consequence
NHLRC1
NM_198586.3 missense
NM_198586.3 missense
Scores
12
5
2
Clinical Significance
Conservation
PhyloP100: 6.56
Genes affected
NHLRC1 (HGNC:21576): (NHL repeat containing E3 ubiquitin protein ligase 1) The protein encoded by this gene is a single subunit E3 ubiquitin ligase. Laforin is polyubiquitinated by the encoded protein. Defects in this intronless gene lead to an accumulation of laforin and onset of Lafora disease, also known as progressive myoclonic epilepsy type 2 (EPM2).[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a zinc_finger_region RING-type (size 46) in uniprot entity NHLC1_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_198586.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.975
PP5
Variant 6-18122402-G-C is Pathogenic according to our data. Variant chr6-18122402-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 2587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-18122402-G-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHLRC1 | NM_198586.3 | c.205C>G | p.Pro69Ala | missense_variant | 1/1 | ENST00000340650.6 | NP_940988.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHLRC1 | ENST00000340650.6 | c.205C>G | p.Pro69Ala | missense_variant | 1/1 | 6 | NM_198586.3 | ENSP00000345464.3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152244Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152244
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000112 AC: 22AN: 196976Hom.: 0 AF XY: 0.0000909 AC XY: 10AN XY: 109964
GnomAD3 exomes
AF:
AC:
22
AN:
196976
Hom.:
AF XY:
AC XY:
10
AN XY:
109964
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000128 AC: 183AN: 1432358Hom.: 0 Cov.: 35 AF XY: 0.000125 AC XY: 89AN XY: 711884
GnomAD4 exome
AF:
AC:
183
AN:
1432358
Hom.:
Cov.:
35
AF XY:
AC XY:
89
AN XY:
711884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74376
GnomAD4 genome
AF:
AC:
12
AN:
152244
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 22, 2020 | The frequency of this variant in the general population is consistent with pathogenicity. Found in at least one patient with expected phenotype for this gene. Predicted to have a damaging effect on the protein. Located in potentially critical domain of the protein. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. Assessment of experimental evidence suggests this variant results in abnormal protein function. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2024 | Affects the RING finger domain and reported as the most common pathogenic variant observed in the NHLRC1 gene (PMID: 16311711); Published functional studies of P69A demonstrate impairment of malin's interaction with laforin resulting in abnormal accumulation of intracellular glycogen (PMID: 15930137, 18029386, 21505799); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21505799, 28556688, 18029386, 15930137, 12958597, 20738377, 16134145, 19744044, 18256682, 15781812, 16529633, 20301563, 29431110, 33773408, 31589614, 31440721, 31758957, 31858178, 25270369, 31227012, 36638890, 33368637, 16311711, 35184210, 36210672) - |
Lafora disease Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 69 of the NHLRC1 protein (p.Pro69Ala). This variant is present in population databases (rs28940576, gnomAD 0.02%). This missense change has been observed in individuals with Lafora disease (PMID: 12958597, 16529633, 18256682, 19744044, 21505799, 22815132). ClinVar contains an entry for this variant (Variation ID: 2587). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NHLRC1 protein function. Experimental studies have shown that this missense change affects NHLRC1 function (PMID: 15930137, 18029386, 21505799). For these reasons, this variant has been classified as Pathogenic. - |
NHLRC1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 20, 2023 | The NHLRC1 c.205C>G variant is predicted to result in the amino acid substitution p.Pro69Ala. This variant has been reported in the homozygous and compound heterozygous states in multiple individuals with Lafora disease (Chan et al. 2003. PubMed ID: 12958597; Franceschetti et al. 2006. PubMed ID: 16529633; RomΓ‘-Mateo et al. 2012. PubMed ID: 22815132). Functional studies showed this variant is detrimental and leads to intracellular glycogen accumulation (Gentry et al. 2005. PubMed ID: 15930137; Couarch et al. 2011. PubMed ID: 21505799). This variant is reported in 0.019% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Myoclonic epilepsy of Lafora 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 22, 2005 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of sheet (P = 0.0016);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at